Consumable Suppliers

ADA Antidrug Antibodies that can develop in patients and can potentially affect drug pharmacokinetics, safety, and efficacy of the injected peptide. ADA response did not affect tirzepatide pharmacokinetics or efficacy during SURPASS Phase 3 FDA trials. API Active pharmaceutical ingredient. The main active ingredient in the vial. i.e. tirzepatide Bacteriostatic water (BAC) Water that has […]